ABSTRACT:
Among the leading illnesses in the globe is diabetes mellitus. It currently affects an estimated143 million people worldwide and the number is growing rapidly. In the India, about 1-5% population suffer from diabetes or related complication. So, there is need to cure this disease. Using HPLC and UPLC, method 1 establishes several analytical techniques for the production of specific anti-diabetic medications, including glibenclamide, ligandulide, nateglinide, sitagliptin, and tolbutamide. This procedure was created with the intention of reviewing the comparability of the published HPLC and UPLC analytical procedures for a specific set of anti-diabetic medications, including Glibenclamide, Tolbutamide, Nateglinide, Sitagliptin, And Liraglutide.
Cite this article:
Sayyad Simran Shabbir, Shaikh Sadiya Mehmood, Ansari Shaheenanjum Babuddin, Pathan Najiya Shahnoor, Dr. Aejaz Ahmed. A Review on Reported Analytical Method Development by UPLC & HPLC of Selected Anti-Diabetic Drugs. IJRPAS, Sep-Oct 2023; 2(5): 152-161
1.
RPUPLC method development and validation
for the determination of Nateglinide in bulk drug and pharmaceutical
formulations: a quality by design approach," research gate2012,
10(1),23-44, Basavaiah Kadakapura, Madathil Cijo, Cijo Xavier, and
Jaganathamurthi, Ramesh.
2.
Development and validation of RP-HPLC
method for quantitative analysis of tolbutamide in pure and pharmaceutical
formulations, D. Madhu Latha, K. Ammani, P. Jitendra Kumar,
tsijournals-2013,11(4),1607-1614.
3.
UPLC: a contemporary chromatographic
technique, Kinjal Shanshyambhai Sheliya and Ketan Shah, research
gate.net-2013,4(3);78.
4.
HPLC: a brief review, Malviya R, Bansal V,
Pal O.P., and Sharma P.K. Journal of Global Pharma Technology, 2010; 2(5):
22–26.
5.
Mazhar Abbas, Ultra Performance Liquid
Chromatography, SlideServe, 2020;9.
6.
Rapid, validated UPLC-MS/MS method for
determination of Glibenclamide in rat plasma," hindawi (international
journal of analytical chemistry) 2018;1–9, Mohd Aftab Alam, Fahad Ibrahim al
Jeonoobi, and Abdullah Mohammed alMohizea.
7.
Development and validation of RP-HPLC
method for metformin hydrochloride and nateglinide in bulk and combined dosage
form, Prasanthi Chengalva, Angala Parameswar S, and Aruna G, International
Journal of Pharmacy and Pharmaceutical Sciences, 2016; 8(4):267-271.
8.
The article "Validated RP-HPLC method
for the estimation of Liraglutide in tablet dosage" was published in the
International Journal of Science Invention Today in 2012 and was written by
P.V.V. Satyanarayana and Alavala Siva Madhavi.
9.
Chellu S. "Simultaneous determination
of Sitagliptin phosphate monohydrate and metformin hydrochloride in tablets by
a validated UPLC method," S.N. Malleswararao, Mulwkutta V Suryanarayana,
and Khagga Mukkanti, National Library of Medicine-2012; 80(1), 139-152.
10. "RP-HPLC
method for the estimation of Glibenclamide in human serum," S.D.
Rajendran, B.K. Philip, R. Gopinath, and B. Suresh, Indian Journal of
Pharmaceutical Science-2007, 69(6), 796-799.
11. Taposh
Gorilla, DR. Padmakar Wah, and P.M.M. Rajesh. "Determination of glp-1
analogue, Liraglutide, by UPLC-MS/MS
12. A.
Agalya, E. Vikram, and Dr. G Abirami Review of Selected Anti-Diabetic Drugs'
Reported Analytical Method Development by UPLC and HPLC published in
International Journal of Pharmaceutical Research and Applications, Volume 6,
Issue 1, January–February 2021.
13. WHO
Diabetes Mellitus Expert Committee. Report No. 2. WHO, Geneva, 1980. Report No.
646.
14. The
Expert Committee on Diabetes Mellitus Diagnosis and Classification. The expert
committee's report on the diagnosis and categorization of type 2 diabetes.
Diabetes Care 20:0183–97, 1997.
15. National
Diabetes Information Centre. Diabetes mellitus classification and diagnosis, as
well as other forms of glucose intolerance. Diabetes 1979;28(10)1039–1059.
16. In
Harrison's Principles of Internal Medicine, 14th edition (Isselbacher, K.J.,
Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S., and Kasper, D.L., eds),
McGraw-Hill, Inc. (Health Professions Division), 1998;2060-2080, Foster, D.W.
Diabetes Mellitus.
17. Pancreatic
Hormones and Antidiabetic Drugs, Karam JH, Basic and Clinical Pharmacology,
Appleton-Lange, 1998; 684-703 (Katzung, B. G., ed.).
18. Fantus
IG and Cheng AY. Type 2 diabetes mellitus treated with oral antihyperglycemic
medication. CMAJ 172(2): 213-26; 2005.